Prediction of membranous nephropathy recurrence after transplantation by monitoring of anti-PLA2R1 (M-type phospholipase A2 receptor) autoantibodies: A case series of 15 patients

Nephrology Dialysis Transplantation

Volumn 29, Issue 12, 2014, Pages 2334-2342

  Seitz Polski, Barbara ^a,b,c   Payré, Christine ^b   Ambrosetti, Damien ^a   Albano, Laetitia ^a   Cassuto Viguier, Elisabeth ^a   Berguignat, Marine ^a   Jeribi, Ahmed ^a   Thouret, Marie Christine ^c   Bernard, Ghislaine ^c   Benzaken, Sylvia ^c   Lambeau, Gérard ^b   Esnault, Vincent L M ^a  

^a PASTEUR HOSPITAL   (France)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Membranous nephropathy; PLA2R1 autoantibodies; Prognosis; Recurrence; Transplantation

Indexed keywords

BASILIXIMAB; CALCINEURIN INHIBITOR; CREATININE; IMMUNOGLOBULIN G4; M TYPE PHOSPHOLIPASE A2 RECEPTOR ANTIBODY; MYCOPHENOLIC ACID; RECEPTOR ANTIBODY; RITUXIMAB; THYMOCYTE ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIBODY; PHOSPHOLIPASE A2 RECEPTOR;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CASE STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATIONAL STUDY; CREATININE BLOOD LEVEL; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MALE; MEMBRANOUS GLOMERULONEPHRITIS; MIDDLE AGED; PREDICTIVE VALUE; PRIORITY JOURNAL; PROTEINURIA; RECURRENT DISEASE; RELAPSE; RETROSPECTIVE STUDY; RISK FACTOR; BIOPSY; GLOMERULONEPHRITIS, MEMBRANOUS; IMMUNOLOGY; METABOLISM; PROGNOSIS;

ADULT; AUTOANTIBODIES; BIOPSY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW-UP STUDIES; GLOMERULONEPHRITIS, MEMBRANOUS; HUMANS; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PROGNOSIS; RECEPTORS, PHOSPHOLIPASE A2; RECURRENCE; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84918592881     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfu252     Document Type: Article

References (27)

1. Glassock RJ. Diagnosis and natural course of membranous nephropathy. Semin Nephrol 2003; 23: 324-332
2. Ronco P, Debiec H. Pathogenesis of membranous nephropathy: recent advances and future challenges. Nat Rev Nephrol 2012; 8: 203-213
3. Ponticelli C, Glassock RJ. Glomerular diseases: membranous nephropathy-a modern view. Clin J Am Soc Nephrol 2014; 9: 609-616
4. Hofstra JM, Fervenza FC, Wetzels JF. Treatment of idiopathic membranous nephropathy. Nat Rev Nephrol 2013; 9: 443-458
5. Dabade TS, Grande JP, Norby SM et al. Recurrent idiopathic membranous nephropathy after kidney transplantation: a surveillance biopsy study. Am J Transplant 2008; 8: 1318-1322
6. Moroni G, Gallelli B, Quaglini S et al. Long-term outcome of renal transplantation in patients with idiopathic membranous glomerulonephritis (MN). Nephrol Dial Transplant 2010; 25: 3408-3415
7. Monga G, Mazzucco G, Basolo B et al. Membranous glomerulonephritis (MGN) in transplanted kidneys: morphologic investigation on 256 renal allografts. Mod Pathol 1993; 6: 249-258
8. Poduval RD, Josephson MA, Javaid B. Treatment of de novo and recurrent membranous nephropathy in renal transplant patients. Semin Nephrol 2003; 23: 392-399
9. Mulay AV, van Walraven C, Knoll GA. Impact of immunosuppressive medication on the risk of renal allograft failure due to recurrent glomerulonephritis. Am J Transplant 2009; 9: 804-811
10. Beck LH, Jr, Bonegio RG, Lambeau G et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 2009; 361: 11-21
11. Qin W, Beck LH, Jr, Zeng C et al. Anti-phospholipase A2 receptor antibody in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1137-1143
12. Hofstra JM, Beck LH, Jr, Beck DM et al. Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membranous nephropathy. Clin J Am Soc Nephrol 2011; 6: 1286-1291
13. Hofstra JM, Debiec H, Short CD et al. Antiphospholipase A2 receptor antibody titer and subclass in idiopathic membranous nephropathy. J Am Soc Nephrol 2012; 23: 1735-1743
14. Dahnrich C, Komorowski L, Probst C et al. Development of a standardized ELISA for the determination of autoantibodies against human M-type phospholipase A2 receptor in primary membranous nephropathy. Clin Chim Acta 2013; 421C:213-218
15. Hoxha E, Harendza S, Zahner G et al. An immunofluorescence test for phospholipase-A2-receptor antibodies and its clinical usefulness in patients with membranous glomerulonephritis. Nephrol Dial Transplant 2011; 26: 2526-2532
16. Beck LH, Jr, Fervenza FC, Beck DM et al. Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy. J Am Soc Nephrol 2011; 22: 1543-1550
17. Kanigicherla D, Gummadova J, McKenzie EA et al. Anti-PLA2R antibodies measured by ELISA predict long-term outcome in a prevalent population of patients with idiopathic membranous nephropathy. Kidney Int 2013; 83: 940-948
18. Hoxha E, Thiele I, Zahner G et al. Phospholipase A2 receptor autoantibodies and clinical outcome in patients with primary membranous nephropathy. J Am Soc Nephrol 2014; 25: 1357-1366.
19. Hoxha E, Kneissler U, Stege G et al. Enhanced expression of the M-type phospholipase A2 receptor in glomeruli correlates with serum receptor antibodies in primary membranous nephropathy. Kidney Int 2012; 82: 797-804
20. Murtas C, Bruschi M, Candiano G et al. Coexistence of different circulating anti-podocyte antibodies in membranous nephropathy. Clin J Am Soc Nephrol 2012; 7: 1394-1400
21. Stahl R, Hoxha E, Fechner K. PLA2R autoantibodies and recurrent membranous nephropathy after transplantation. N Engl JMed 2010; 363: 496-498
22. Debiec H, Martin L, Jouanneau C et al. Autoantibodies specific for the phospholipase A2 receptor in recurrent and de novo membranous nephropathy. Am J Transplant 2011; 11: 2144-2152
23. Ancian P, Lambeau G, Mattéi MG et al. The human 180-kDa receptor for secretory phospholipases A2. Molecular cloning, identification of a secreted soluble form, expression, and chromosomal localization. J Biol Chem 1995; 270: 8963-8970
24. LambeauG, Ancian P, Barhanin J et al. Cloning and expression of a membrane receptor for secretory phospholipases A2. J Biol Chem 1994; 269: 1575-1578
25. Rouault M, Le Calvez C, Boilard E et al. Recombinant production and properties of binding of the full set of mouse secreted phospholipases A2 to the mouse M-type receptor. Biochemistry 2007; 46: 1647-1662
26. Saleem MA, O'Hare MJ, Reiser J et al. A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002; 13: 630-638
27. Prunotto M, Carnevali ML, Candiano G et al. Autoimmunity in membranous nephropathy targets aldose reductase and SOD2. J Am Soc Nephrol 2010; 21: 507-519